×




Mark Logan @ Visx, Inc. (A) Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Mark Logan @ Visx, Inc. (A) case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Mark Logan @ Visx, Inc. (A) case study is a Harvard Business School (HBR) case study written by Gosia Glinska, Philippe Sommer. The Mark Logan @ Visx, Inc. (A) (referred as “Visx Fda” from here on) case study provides evaluation & decision scenario in field of Organizational Development. It also touches upon business topics such as - Value proposition, Government, Product development.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Mark Logan @ Visx, Inc. (A) Case Study


Since 1986, Visx had been guiding several procedures to treat corneal pathologies and refractive eye disorders through the multistage FDA approval process. The costs associated with submitting clinical trial information to the FDA were taking a toll. Problems increased dramatically in September 1994, when Visx's stock price fell 26% with the news that FDA approval was delayed because of compliance irregularities found at some clinical testing sites. And that same year, its revenues dropped by 19%. Getting FDA approval was extremely important to Visx, as it would have its foot in the door and be able to sell its excimer laser system in the United States. The persistent sentiment among the management team was that even though Visx had a technologically superior laser system, which consistently received top ranking from the world's leading ophthalmologists, Visx's competition was going to win the race to gain FDA approval by virtue of being relentlessly aggressive and street smart.


Case Authors : Gosia Glinska, Philippe Sommer

Topic : Organizational Development

Related Areas : Government, Product development




Calculating Net Present Value (NPV) at 6% for Mark Logan @ Visx, Inc. (A) Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10029206) -10029206 - -
Year 1 3465911 -6563295 3465911 0.9434 3269727
Year 2 3980405 -2582890 7446316 0.89 3542546
Year 3 3945049 1362159 11391365 0.8396 3312339
Year 4 3238183 4600342 14629548 0.7921 2564944
TOTAL 14629548 12689557




The Net Present Value at 6% discount rate is 2660351

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Net Present Value
2. Internal Rate of Return
3. Payback Period
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Visx Fda shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Visx Fda have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Mark Logan @ Visx, Inc. (A)

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Organizational Development Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Visx Fda often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Visx Fda needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10029206) -10029206 - -
Year 1 3465911 -6563295 3465911 0.8696 3013836
Year 2 3980405 -2582890 7446316 0.7561 3009758
Year 3 3945049 1362159 11391365 0.6575 2593934
Year 4 3238183 4600342 14629548 0.5718 1851442
TOTAL 10468969


The Net NPV after 4 years is 439763

(10468969 - 10029206 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10029206) -10029206 - -
Year 1 3465911 -6563295 3465911 0.8333 2888259
Year 2 3980405 -2582890 7446316 0.6944 2764170
Year 3 3945049 1362159 11391365 0.5787 2283014
Year 4 3238183 4600342 14629548 0.4823 1561624
TOTAL 9497068


The Net NPV after 4 years is -532138

At 20% discount rate the NPV is negative (9497068 - 10029206 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Visx Fda to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Visx Fda has a NPV value higher than Zero then finance managers at Visx Fda can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Visx Fda, then the stock price of the Visx Fda should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Visx Fda should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What can impact the cash flow of the project.

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Mark Logan @ Visx, Inc. (A)

References & Further Readings

Gosia Glinska, Philippe Sommer (2018), "Mark Logan @ Visx, Inc. (A) Harvard Business Review Case Study. Published by HBR Publications.


Fukuoka Reit SWOT Analysis / TOWS Matrix

Services , Real Estate Operations


SL Corp SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Parts


Oracle SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Emerge Gaming SWOT Analysis / TOWS Matrix

Technology , Computer Services


Cincinnati Financial SWOT Analysis / TOWS Matrix

Financial , Insurance (Prop. & Casualty)


Kinder Morgan SWOT Analysis / TOWS Matrix

Utilities , Natural Gas Utilities


Kawasaki Heavy Industries SWOT Analysis / TOWS Matrix

Consumer Cyclical , Recreational Products


NanoCarrier SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs